Daan Gene Co., Ltd. (SHE:002030)
6.02
+0.01 (0.17%)
May 23, 2025, 2:45 PM CST
Daan Gene Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 814.58 | 843.75 | 1,173 | 12,040 | 7,615 | 5,330 | Upgrade
|
Other Revenue | 9.27 | 9.27 | 8 | 6.08 | 48.84 | 10.93 | Upgrade
|
Revenue | 823.85 | 853.02 | 1,181 | 12,046 | 7,664 | 5,341 | Upgrade
|
Revenue Growth (YoY) | -20.64% | -27.77% | -90.20% | 57.17% | 43.49% | 386.35% | Upgrade
|
Cost of Revenue | 658.64 | 629.58 | 801.12 | 3,615 | 1,963 | 1,605 | Upgrade
|
Gross Profit | 165.21 | 223.44 | 379.78 | 8,431 | 5,701 | 3,736 | Upgrade
|
Selling, General & Admin | 331.4 | 333.32 | 300.68 | 1,246 | 1,124 | 888.63 | Upgrade
|
Research & Development | 223.21 | 225.67 | 302.33 | 702.4 | 508.8 | 166.95 | Upgrade
|
Other Operating Expenses | -17.35 | -18.22 | -8.56 | 101.03 | 36.34 | -9.57 | Upgrade
|
Operating Expenses | 906.67 | 936.47 | 735.82 | 2,347 | 1,800 | 1,191 | Upgrade
|
Operating Income | -741.46 | -713.02 | -356.04 | 6,084 | 3,901 | 2,545 | Upgrade
|
Interest Expense | -8.81 | -9.74 | -10.04 | -13.94 | -9.35 | -22.44 | Upgrade
|
Interest & Investment Income | 64.07 | 69.37 | 83.1 | 370.86 | 266.7 | 154.27 | Upgrade
|
Currency Exchange Gain (Loss) | 5.85 | 5.85 | 2.28 | 25.72 | -1.85 | -9.3 | Upgrade
|
Other Non Operating Income (Expenses) | -4.75 | -4.07 | -12.77 | -22.07 | -12.56 | -31.81 | Upgrade
|
EBT Excluding Unusual Items | -685.1 | -651.62 | -293.48 | 6,445 | 4,144 | 2,635 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -4.2 | Upgrade
|
Gain (Loss) on Sale of Investments | 134.06 | -429.58 | 409.44 | 73.97 | -83.78 | 286.23 | Upgrade
|
Gain (Loss) on Sale of Assets | 9.69 | 9.1 | -3.04 | -1.15 | 0.11 | 0.14 | Upgrade
|
Asset Writedown | -14.2 | -10.65 | -59.48 | -256.35 | -15 | -14.52 | Upgrade
|
Legal Settlements | 0.07 | 0.07 | 1.42 | 0.46 | - | - | Upgrade
|
Other Unusual Items | 12.21 | 11.52 | 58.67 | 57.22 | 74.44 | -0.05 | Upgrade
|
Pretax Income | -543.27 | -1,071 | 113.54 | 6,319 | 4,120 | 2,903 | Upgrade
|
Income Tax Expense | -16.56 | -132.05 | 41.8 | 891.38 | 501.59 | 452.82 | Upgrade
|
Earnings From Continuing Operations | -526.71 | -939.11 | 71.73 | 5,428 | 3,618 | 2,450 | Upgrade
|
Net Income to Company | -526.71 | -939.11 | 71.73 | 5,428 | 3,618 | 2,450 | Upgrade
|
Minority Interest in Earnings | 17.75 | 13.94 | 32.93 | -15.22 | -0.3 | -0.95 | Upgrade
|
Net Income | -508.95 | -925.17 | 104.66 | 5,412 | 3,618 | 2,449 | Upgrade
|
Net Income to Common | -508.95 | -925.17 | 104.66 | 5,412 | 3,618 | 2,449 | Upgrade
|
Net Income Growth | - | - | -98.07% | 49.59% | 47.74% | 2556.80% | Upgrade
|
Shares Outstanding (Basic) | 1,383 | 1,402 | 1,495 | 1,403 | 1,403 | 1,403 | Upgrade
|
Shares Outstanding (Diluted) | 1,383 | 1,402 | 1,495 | 1,403 | 1,403 | 1,403 | Upgrade
|
Shares Change (YoY) | -7.43% | -6.25% | 6.53% | - | - | - | Upgrade
|
EPS (Basic) | -0.37 | -0.66 | 0.07 | 3.86 | 2.58 | 1.75 | Upgrade
|
EPS (Diluted) | -0.37 | -0.66 | 0.07 | 3.86 | 2.58 | 1.75 | Upgrade
|
EPS Growth | - | - | -98.19% | 49.59% | 47.74% | 2556.82% | Upgrade
|
Free Cash Flow | 218.19 | 125.92 | 207.34 | 2,652 | 2,646 | 2,150 | Upgrade
|
Free Cash Flow Per Share | 0.16 | 0.09 | 0.14 | 1.89 | 1.89 | 1.53 | Upgrade
|
Dividend Per Share | - | - | 0.015 | 1.750 | 1.110 | 0.344 | Upgrade
|
Dividend Growth | - | - | -99.14% | 57.66% | 222.86% | 2321.13% | Upgrade
|
Gross Margin | 20.05% | 26.19% | 32.16% | 69.99% | 74.39% | 69.94% | Upgrade
|
Operating Margin | -90.00% | -83.59% | -30.15% | 50.51% | 50.90% | 47.64% | Upgrade
|
Profit Margin | -61.78% | -108.46% | 8.86% | 44.93% | 47.21% | 45.85% | Upgrade
|
Free Cash Flow Margin | 26.48% | 14.76% | 17.56% | 22.02% | 34.52% | 40.25% | Upgrade
|
EBITDA | -404.07 | -374.26 | -11.82 | 6,347 | 4,093 | 2,617 | Upgrade
|
EBITDA Margin | -49.05% | -43.88% | -1.00% | 52.69% | 53.41% | 48.99% | Upgrade
|
D&A For EBITDA | 337.39 | 338.76 | 344.23 | 262.88 | 192.02 | 72 | Upgrade
|
EBIT | -741.46 | -713.02 | -356.04 | 6,084 | 3,901 | 2,545 | Upgrade
|
EBIT Margin | -90.00% | -83.59% | -30.15% | 50.51% | 50.90% | 47.64% | Upgrade
|
Effective Tax Rate | - | - | 36.82% | 14.11% | 12.17% | 15.60% | Upgrade
|
Revenue as Reported | 823.85 | 853.02 | 1,181 | 12,046 | 7,664 | 5,341 | Upgrade
|
Advertising Expenses | - | - | - | - | - | 1.38 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.